Skip to content

Application of disposable visual ultra-fine diameter appendiceal endoscopy

Application of disposable visual ultra-fine diameter appendiceal endoscopy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081465
Enrollment
Unknown
Registered
2024-03-01
Start date
2024-03-02
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Appendicitis

Interventions

ERAT group:Endoscopic Retrograde Appendicitis Treatment,ERAT
modified ERAT group:modified-Endoscopic Retrograde Appendicitis Treatment

Sponsors

The Second Hospital Lanzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patient age over 14 years and under 80 years; (2) Alvarado score>5; (3) Suspicious (or could not be excluded) acute appendicitis diagnosed by an abdominal CT scan, which was indicated by a dilated appendix with a diameter greater than 6mm, a thickened cecal wall, and periappendiceal fat infammation, with or without an appendicolith

Exclusion criteria

Exclusion criteria: (1) suspected acute complicated appendicitis with perforation or gangrene; (2) appendiceal diameter greater than 15mm, which usually indicates malignancy; (3) patients with the following contradictions for receiving colonoscopy, surgery or anesthesia: (a) severe cardiopulmonary insufciency, psychiatric dysfunction or coma; (b) acute difuse peritonitis, which is defned as difuse abdominal tenderness, rebound tenderness and muscular tension; (c) acute gastroenteritis (dysentery, explosive ulcerative colitis); (d) concurrent menses; (e) intestinal obstruction; (f) acute gastrointestinal hemorrhage; (g) recent gastrointestinal or pelvic operation or radiotherapy; (h) allergy to contrast medium; (i) hemorrhagic tendency because of longterm use of corticosteroids or anticoagulant treatment; (4) patients undergoing any other clinical trial.

Design outcomes

Primary

MeasureTime frame
the clinical success of the treatment;The appendix was successfully intubated;

Secondary

MeasureTime frame
Duration of post-treated pain;The overall complication rate;LOS (length of stay);Duration of post-treated pain;Time for inflammation markers to return to normal;

Countries

China

Contacts

Public ContactHuimin Ma

The Second Hospital Lanzhou University

mahuimin1986@163.com+86 182 1510 2289

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026